Immunomedics, Inc. (IMMU) financial statements (2020 and earlier)

Company profile

Business Address 300 AMERICAN RD
MORRIS PLAINS, NJ 07950
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:613639155511004241
Cash and cash equivalents609612431313741
Short-term investments5271123786  
Other undisclosed cash, cash equivalents, and short-term investments (0)(0)(0)(0)35 
Receivables0011111
Inventory, net of allowances, customer advances and progress billings  10111
Inventory  10111
Prepaid expense22411110
Other current assets3600101
Other undisclosed current assets 000001
Total current assets:639648157531034545
Noncurrent Assets
Property, plant and equipment331654222
Regulated entity, other noncurrent assets    3  
Other noncurrent assets0000000
Other undisclosed noncurrent assets    (3)01
Total noncurrent assets:331654223
TOTAL ASSETS:672664163571064748
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:613231151264
Accounts payable3825553  
Accrued liabilities    0  
Employee-related liabilities7  1111
Interest and dividends payable  222  
Other undisclosed accounts payable and accrued liabilities167247663
Debt7      
Deferred revenue and credits0000  
Other undisclosed current liabilities31291  03
Total current liabilities:7244122151267
Noncurrent Liabilities
Long-term debt and lease obligation1020989797  
Long-term debt, excluding current maturities 20989797  
Operating lease, liability10
Liabilities, other than long-term debt75222221
Deferred revenue65
Other liabilities10222221
Other undisclosed noncurrent liabilities248199     
Total noncurrent liabilities:333221100999821
Total liabilities:40426422211411088
Stockholders' equity
Stockholders' equity attributable to parent, including:268401(59)(57)(4)3940
Common stock2211111
Treasury stock, value(2)(0)(0)(0)(0)(0)(0)
Additional paid in capital1,5791,195463311305300266
Accumulated other comprehensive income (loss)(1)(0)(0)(0)(0)00
Accumulated deficit(1,310)(796)(522)(369)(309)(261)(226)
Other undisclosed stockholders' equity attributable to parent  0    
Stockholders' equity attributable to noncontrolling interest(1)(1)(1)(1)(1)(0)(0)
Total stockholders' equity:267400(59)(58)(5)3940
TOTAL LIABILITIES AND EQUITY:672664163571064748

Income statement (P&L) ($ in millions)

12/31/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Revenues0233695
Revenue, net233695
Cost of revenue (1)(0)(1) (2)(3)
Cost of goods and services sold (1)(0)(1) (2)(0)
Gross profit:0232682
Operating expenses(325)(143)(82)(61)(52)(44)(33)
Other undisclosed operating income 282  01 
Operating income (loss):(325)141(79)(59)(46)(36)(31)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
 00(0)(0)0(0)
Interest and debt expense(40)(23)(5)(5)(2)  
Other undisclosed income from continuing operations before equity method investments, income taxes     019
Income (loss) from continuing operations before equity method investments, income taxes:(365)118(85)(65)(48)(36)(11)
Other undisclosed income (loss) from continuing operations before income taxes8(392)(69)00  
Loss from continuing operations before income taxes:(357)(274)(153)(64)(48)(36)(11)
Income tax expense (benefit) (0)(0)5(0)(0)(0)
Net loss:(357)(274)(153)(59)(48)(36)(11)
Net income attributable to noncontrolling interest0000000
Net loss available to common stockholders, diluted:(357)(274)(153)(59)(48)(35)(11)

Comprehensive Income ($ in millions)

12/31/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Net loss:(357)(274)(153)(59)(48)(36)(11)
Other comprehensive income (loss)(0)(0)(0)0(0)00
Other undisclosed comprehensive income     3612
Comprehensive income (loss):(358)(274)(153)(59)(49)00
Comprehensive income (loss), net of tax, attributable to noncontrolling interest00000(0)(0)
Other undisclosed comprehensive loss, net of tax, attributable to parent     (35)(11)
Comprehensive loss, net of tax, attributable to parent:(357)(274)(153)(59)(48)(35)(11)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: